Brenton Todd Flatt

USPTO Granted Patents = 21 (Patent Applications = 1)

CIPO Patents = 5

EPO Patents = 8 (Patent Applications = 5)

Average Co-Inventor Count = 5.9

ph-index = 8

Forward Citations = 233(Granted Patents)

Location History:

Poway, CA (US) (2002 - 2015)
San Diego, CA (US) (2013 - 2015)

Company Filing History:

Exelixis Patent Company LLC

patents

2 out of 4

X-ceptor Therapeutics, Inc.

Years Active: 2002-2015

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9102671 - Compounds and compositions as TRK inhibitors (2015-08-11),

2. 9000022 - Imidazole based LXR modulators (2015-04-07),

3. 8846739 - TGR5 agonists (2014-09-30),

4. 8785488 - Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesity (2014-07-22),

5. 8748440 - Quinazolinone modulators of nuclear receptors (2014-06-10),

6. 8703805 - Modulators of LXR (2014-04-22),

7. 8637516 - Compounds and compositions as TRK inhibitors (2014-01-28),

8. 8569352 - Imidazole based LXR modulators (2013-10-29),

9. 8524704 - Azepinoindole derivatives as pharmaceutical agents (2013-09-03),

10. 8466143 - Azepine derivatives as pharmaceutical agents (2013-06-18),

11. 8367667 - Pyrrole derivatives as pharmaceutical agents (2013-02-05),

12. 8163771 - 11 β-HSD1 modulators (2012-04-24),

13. 8133992 - Azepinoindole and pyridoindole derivatives as pharmaceutical agents (2012-03-13),

14. 8026237 - Pyrrole derivatives as pharmaceutical agents (2011-09-27),

15. 7902237 - Heterocyclic compounds as pharmaceutical agents (2011-03-08),

Title: The Inventive Journey of Brenton Todd Flatt

Introduction

In the realm of innovation and patents, Poway, CA (US) is home to Brenton Todd Flatt, a prolific inventor with an impressive 21 patents to his name. His groundbreaking work has significantly contributed to the advancement of science and medicine.

Latest Patents

Brenton Todd Flatt's latest patents showcase his expertise in the field of pharmaceuticals and disease treatment. His inventions include compounds and compositions as TRK inhibitors, aimed at addressing diseases associated with abnormal TRK kinase activity. Additionally, his work on imidazole-based LXR modulators highlights his commitment to developing novel methods for treating various disorders affected by nuclear receptor activity.

Career Highlights

Flatt's remarkable career includes tenure at renowned companies such as Exelixis, Inc. and Exelixis Patent Company LLC. His innovative contributions have not only shaped the industry but have also paved the way for future advancements in pharmaceutical research and development.

Collaborations

Throughout his career, Brenton Todd Flatt has collaborated with esteemed professionals in the field, including Richard Martin and Tie-Lin Wang. These partnerships have fostered a culture of innovation and collaboration, allowing for the exchange of ideas and expertise.

Conclusion

Brenton Todd Flatt's dedication to innovation and his prolific patent portfolio underscore his status as a trailblazer in the field of pharmaceutical research. His inventive spirit and collaborative efforts continue to inspire future generations of inventors, shaping the landscape of scientific discovery for years to come.

This text is generated by artificial intelligence and may not be accurate.